Resources
Latest Resources
Follow the Money The Oversight Gap at the Center of 340B
Intellectual Property America’s Competitive Advantage
BRG Report The Size of the 340B Program
About PhRMA
RFI Categories Used in Federal Vaccine Recommendations and the Role of Shared Clinical Decision making
Every Patent Stands Alone Debunking the Evergreening Myth
Better Medicines Not Meaningless Tweaks Debunking the Product Hopping Myth
340B Big Tax exempt Hospitals are Pocketing Billions by Exploiting a Federal Safety Net Program at the Expense of Taxpayers
PhRMA Comments on Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program Proposed Rule CMS 4215
Explore Member-only Resources
Access exclusive advocacy, policy and research materials through the member site.
PhRMA Connect